Plant Polyisoprenoids and Control of Cholesterol Level

被引:22
作者
Pronin, Alexander V. [1 ]
Danilov, Leonid L. [2 ]
Narovlyansky, Alexander N. [1 ]
Sanin, Alexander V. [1 ]
机构
[1] NF Gamalei Inst Epidemiol & Microbiol, Moscow, Russia
[2] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia
关键词
Polyisoprenoids; beta-Sitosterol; Sitopren; Cholesterol; Atherosclerosis; PHOSPHATE BIOSYNTHESIS; POLYPRENYL-PHOSPHATES; MEVALONATE PATHWAY; DOLICHOL; GLYCOSYLATION; MODEL; MEMBRANES; DISORDER; RATS; LIFE;
D O I
10.1007/s00005-013-0253-y
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability of plant polyisoprenoids (polyprenols and polyprenyl phosphates) to diminish the levels of serum cholesterol affecting its biosynthetic pathway are highlighted here. Possible mechanism of such process is discussed. It is also noted that polyisoprenoids can prevent toxic injuries of the liver and restore disturbed hepatic functions. The possibility of polyprenyl phosphates to reveal at the same time anti-inflammatory action suppressing lipoxygenase activity and lowering the levels of proinflammatory cytokines will be illustrated. Attention will be focused on the potential usefulness of plant polyisoprenoids in the course of prevention and treatment of hypercholesterolemia. High efficiency for combined use of polyprenyl phosphate and beta-sitosterol, which leads to substantial enhancement of the ability to overcome hypercholesterolemia versus the individual constituents will be demonstrated.
引用
收藏
页码:31 / 39
页数:9
相关论文
共 53 条
[1]   Adverse Effects of Statins - Mechanisms and Consequences [J].
Beltowski, Jerzy ;
Wojcicka, Grazyna ;
Jamroz-Wisniewska, Anna .
CURRENT DRUG SAFETY, 2009, 4 (03) :209-228
[2]  
Bergamini E, 2004, J ALZHEIMERS DIS, V6, P129
[3]   Glycosylation defects underlying fetal alcohol spectrum disorder: a novel pathogenetic model "When the wine goes in, strange things come out" - S.T. Coleridge, The Piccolomini [J].
Binkhorst, M. ;
Wortmann, S. B. ;
Funke, S. ;
Kozicz, T. ;
Wevers, R. A. ;
Morava, E. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 (03) :399-405
[4]   Host Defense against Viral Infection Involves Interferon Mediated Down-Regulation of Sterol Biosynthesis [J].
Blanc, Mathieu ;
Hsieh, Wei Yuan ;
Robertson, Kevin A. ;
Watterson, Steven ;
Shui, Guanghou ;
Lacaze, Paul ;
Khondoker, Mizanur ;
Dickinson, Paul ;
Sing, Garwin ;
Rodriguez-Martin, Sara ;
Phelan, Peter ;
Forster, Thorsten ;
Strobl, Birgit ;
Mueller, Matthias ;
Riemersma, Rudolph ;
Osborne, Timothy ;
Wenk, Markus R. ;
Angulo, Ana ;
Ghazal, Peter .
PLOS BIOLOGY, 2011, 9 (03)
[5]   Lipid mediators as agonists for the resolution of acute lung inflammation and injury [J].
Bonnans, Caroline ;
Levy, Bruce D. .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2007, 36 (02) :201-205
[6]   Mevalonate pathway: A review of clinical and therapeutical implications [J].
Buhaescu, Irina ;
Izzedine, Hassane .
CLINICAL BIOCHEMISTRY, 2007, 40 (9-10) :575-584
[7]   From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases [J].
Cantagrel, Vincent ;
Lefeber, Dirk J. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (04) :859-867
[8]   SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder [J].
Cantagrel, Vincent ;
Lefeber, Dirk J. ;
Ng, Bobby G. ;
Guan, Ziqiang ;
Silhavy, Jennifer L. ;
Bielas, Stephanie L. ;
Lehle, Ludwig ;
Hombauer, Hans ;
Adamowicz, Maciej ;
Swiezewska, Ewa ;
De Brouwer, Arjan P. ;
Bluemel, Peter ;
Sykut-Cegielska, Jolanta ;
Houliston, Scott ;
Swistun, Dominika ;
Ali, Bassam R. ;
Dobyns, William B. ;
Babovic-Vuksanovic, Dusica ;
van Bokhoven, Hans ;
Wevers, Ron A. ;
Raetz, Christian R. H. ;
Freeze, Hudson H. ;
Morava, Eva ;
Al-Gazali, Lihadh ;
Gleeson, Joseph G. .
CELL, 2010, 142 (02) :203-217
[9]  
CHOJNACKI T, 1988, BIOCHEM J, V251, P1
[10]  
Danilov Leonid L., 1996, Archivum Immunologiae et Therapiae Experimentalis, V44, P395